New injection shows promise in reversing dangerous liver scarring
Disease control
Completed
This study tested whether a new drug called BIO89-100 could help people with a serious fatty liver disease called NASH. 222 adults with confirmed liver scarring received either the drug or a placebo injection weekly for 24 weeks. Researchers checked if the treatment could reduce …
Phase: PHASE2 • Sponsor: 89bio, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC